Publication | Open Access
Circulating Sfrp5 Is a Signature of Obesity-Related Metabolic Disorders and Is Regulated by Glucose and Liraglutide in Humans
128
Citations
16
References
2012
Year
We conclude that circulating Sfrp5 is likely to play a major role in insulin resistance in humans.
| Year | Citations | |
|---|---|---|
Page 1
Page 1